Immunotherapy for the Prevention and Treatment of Type 1 Diabetes
Authors:
Open Access
- 1 October 2009
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (10) , 1769-1782
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes MellitusJAMA, 2009
- Do Non-HLA Genes Influence Development of Persistent Islet Autoimmunity and Type 1 Diabetes in Children With High-Risk HLA-DR,DQ Genotypes?Diabetes, 2009
- Taking a Daily Vitamin to Prevent Type 1 Diabetes?Diabetes, 2009
- The Environmental Determinants of Diabetes in the Young (TEDDY) StudyAnnals of the New York Academy of Sciences, 2008
- Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety studyClinical and Experimental Immunology, 2008
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 DiabetesNew England Journal of Medicine, 2008
- Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical dataPediatric Diabetes, 2008
- Translational Mini-Review Series on Type 1 Diabetes: Immune-based therapeutic approaches for type 1 diabetesClinical and Experimental Immunology, 2007
- Extreme genetic risk for type 1A diabetesProceedings of the National Academy of Sciences, 2006
- Polyclonal Anti-T-Cell Therapy for Type 1 Diabetes Mellitus of Recent OnsetThe Review of Diabetic Studies, 2004